期刊文献+

艰难梭菌毒素A原核表达及重组蛋白纯化 被引量:2

Prokaryotic expression and recombinant protein purification of Clostridium difficile toxin A
原文传递
导出
摘要 目的构建艰难梭菌(Clostridium difficile,C.difficile)毒素A羧基末端原核表达载体,优化诱导表达条件及纯化重组蛋白。方法利用聚合酶链式反应扩增C.difficile毒素A羧基末端基因序列,并将此序列转入pET-28b载体,构建pET-28b-tcdA重组表达载体,并将表达载体转化到BL21(DE3)感受态大肠埃希菌细胞中,分别在不同条件下进行诱导表达,获得最佳诱导表达条件后进行大量表达,最后用Ni柱对重组蛋白进行亲和纯化,得到纯化后的重组蛋白。结果成功构建了pET-28b-tcdA重组表达载体,其重组蛋白表达最佳诱导条件:菌液吸光度值取0.6、温度取25℃、IPTG终浓度取1.0mmol/L、诱导时间取10h。蛋白纯化咪唑磷酸盐洗脱液最佳浓度取200mmol/L。结论成功构建pET-28b-tcdA重组表达载体,在大肠埃希菌BL21(DE3)中可以有效表达,并获得高浓度重组蛋白,为进一步制备TcdA适配子奠定了一定实验室基础。 Objective To construct the prokaryotic expression vector of Clostridium difficile(C.difficile)toxin A carboxyl terminus,optimize the induction conditions and purify the recombinant protein.MethodsPolymerase chain reaction method was used to amplify the sequence of C.difficiletoxin A carboxyl terminus.The gene sequences of C.difficile toxin A carboxyl terminus was inserted into pET-28 bvector to construct the recombinant expression vector pET-28b-tcdA.The recombinant vector pET-28b-tcdA was transformed into BL21(DE3)competent E.coli to express the recombinant toxin A protein under different induction conditions.A large number of recombinant proteins were expressed by BL21 E.coli with pET-28 btcdA vector under the optimum expression conditions.The recombinant protein was purified by using nickel column with affinity chromatography.Results The recombinant expression vector pET-28b-tcdA was successfully constructed,the optimum expression conditions of which in BL21 E.coli were as follows:A600nm was 0.6,incubation temperature was 25℃,the final concentration of Isopropylβ-D-1-thiogalactopyranoside(IPTG)was 1.0mmol/L and IPTG induction incubation time was 10 hours.The optimum eluent concentration of imidazole phosphate buffer was 200mmol/L during recombinant protein purification.Conclusion The recombinant pET-28b-tcdA vector was effectively expressed in BL21(DE3)E.coli and high concentration of recombinant proteins were acquired,which laid a foundation for the research on the aptamer of C.difficile toxin A.
出处 《中国微生态学杂志》 CAS CSCD 2016年第4期400-404,共5页 Chinese Journal of Microecology
基金 广州市科技计划项目书(201510010241)
关键词 艰难梭菌毒素A 原核表达 重组蛋白纯化 Clostridium difficile toxin A Prokaryotic expression Recombinant protein purification
  • 相关文献

参考文献14

  • 1Eekert C, Emirian A, Le Monnier A, et al. Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B[J]. New Microbes New Infect, 2015, 3(无): 12-17.
  • 2Jank T, Aktories K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model[J]. Trends in Microbi- ol, 2008, 16(5): 222-229.
  • 3Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in diseasd[J].Clin Microbiol Rev, 2005, 18 (2) : 247-263.
  • 4McDonald LC, Killgore GE, Thompson A, et al. An epidem- ic, toxin gene variant strain of Clostridiurn difficile[J]. NE- JM, 2005, 353(23): 2433-2441.
  • 5Planche T, Wilcox M. Reference assays for Clostridium diffi cile infection: one or two gold standards? [J]. J Clin Patbol, 2011, 64(1): 1 5.
  • 6温海楠,杨靖,赵建宏,强翠欣,李志荣,宋文杰,李继红,时东彦,魏宏莲,孙倩,王向红,郭玉梅.住院非腹泻儿童艰难梭菌的定植及相关特征[J].中国微生态学杂志,2015,27(8):895-899. 被引量:3
  • 7Albesa-Jov6 D, Bertrand T, Carpenter EP, et al. Four distinct structural domains in Clostridium diffieile toxin B visualized u- sing SAXS[J]. J Mol Biol, 2010, 396(5): 1260-1270.
  • 8Pruitt RN, Lacy DB. Toward a structural understanding of Clostridium diffieile toxins A and B[J]. Front in Cell &- Infect Microbiol, 2012, 2(28).
  • 9Frisch C, Gerhard R, Aktories K, et al. The complete recep- tor-binding domain of Clostridium difficile toxin A is required for endocytosis[J]. Bioehem &. Biophys Res Commun, 2003, 300(3): 706-711.
  • 10Huang J, Shen Z, Lien S, et al. Biochemical and immunologi- cal characterization of truncated fragments of the receptor- binding domains of C. difficile toxin A[J]. PLoS One, 2015, 10(8):e135045.

二级参考文献23

  • 1Cheng VC, Yam WC, Chan JF, et al. Clostridium difficile ribo- type 027 arrives in Hong Kong[J]. Int J Antimicrob Agents, 2009, 34(5): 492-493.
  • 2David A, Enoch, Matthew J, et al. Clostridium diffieile in chil- dren: Colonisation and disease[J]. J Infect, 2011, 63(2): 105-113.
  • 3Vivian G, Bourgault A, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization[J]. N Engl J Med, 2011, 365(18): 1693-1703.
  • 4Bryant K, McDonald L. Clostridium difficile infections in chil- dren[J]. Pediatr Infect Dis J, 2009, 28(2): 145-146.
  • 5Kato N, Ou CY, Kato H, et al. Identification of toxigenic Clos- tridium difficile by the polymerase chain reaction[J].J Clin Microbiol, 1991, 29(1) : 33-37.
  • 6Kato H, Kato N, Watanabe K, et al. Identification of Toxin A; negative, Toxin B-positive Clostridium difficile by PCR[J]. J Clin Microbiol, 1998, 36 (8): 2178-2182.
  • 7Tubbs S, Rupnik M, Gibert M, et al. Production of actin-spe- cific ADP-ribosyltransferase (binary toxin) by strains of Clos- tridium difficile[J]. FEMS Microbiol Lett, 2000, 186 (2) : 307-312.
  • 8Bryant K, McDonald L. Clostridium difficile infections in chil dren[J]. Pediatr Infect Dis J, 2009, 28(2) : 145-146.
  • 9Bolton RP, Tait SK, Dear PR, et al. Asymptomatic neonatal colonisation by Clostridiurn difficile[J]. Arch Dis Child, 1984, 59(5): 466-472.
  • 10Brazier JS. The epidemiology and typing of Clostridium difficile [J].J Antimicrob Chemother, 1998, 41(1): 47-57.

共引文献2

同被引文献4

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部